ADDENDUM TO: NIAID PROGRAM ANNOUNCEMENT PA-01-113 RELEASE DATE: December 19, 2003 NOTICE: NOT-AI-04-014 National Institute of Allergy and Infectious Diseases (NIAID) This is to clarify that this Program Announcement, PA-01-113, THERAPEUTICS RESEARCH ON AIDS-ASSOCIATED OPPORTUNISTIC INFECTIONS AND MALIGNANCIES that appeared in the NIH Guide on June 28, 2001 at http://grants.nih.gov/grants/guide/pa-files/PA-01-113.html will continue to be accepted by the National Cancer Institute and National Institute of Dental and Craniofacial Research. The Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID) will no longer participate in this Program Announcement, PA-01-113. The final receipt date for applications to NIAID was September 1, 2003. However this PA does not expire until May 2, 2004. INQUIRIES Kenneth Cremer, PhD Division of Cancer Biology National Cancer Institute Room 5016 6130 Executive Boulevard, MSC 7398 Bethesda, MD 20892-7398 Telephone: 301-496-6085 FAX: 301-496-2025 Email: [email protected] Dennis F. Mangan, Ph.D. Division of Extramural Research National Institute of Dental and Craniofacial Research Building 45, Room 4AN-32F, MSC 6402 Bethesda, MD 20892-6402 Telephone: 301-594-2421 FAX: 301-480-8318 Email: [email protected] The National Heart, Lung, and Blood Institute (NHLBI) has an interest in supporting research on the pulmonary, cardiovascular and hematologic aspects of opportunistic infections associated with HIV infection. Therefore, applications of interest are likely to be given a may be primary or secondary assignment to NHLBI in accordance with the NIH referral guidelines. Inquiries regarding NHLBI programmatic issues may be directed to: Hannah H. Peavy, M.D. Division of Lung Diseases National Heart, Lung, and Blood Institute 6701 Rockledge Drive, Suite 10018, MSC 7952 Bethesda, MD 20892-7952 Telephone: 301-435-0222 FAX: 301-480-3557 Email: [email protected] The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has an interest in supporting research on the influence of opportunistic pathogens on the enterocytes in the gastrointestinal tract as well as the hepatocytes in the liver in liver disease expression. Therefore, applications of interest are likely to be given a may be primary or secondary assignment to NIDDK in accordance with the NIH referral guidelines. Inquiries regarding NIDDK programmatic issues may be directed to: Frank A. Hamilton, M.D., Ph.D. Chief, Digestive Diseases Program Branch Room 6AN12B DDDN/NIDDK Natcher Building 45 45 Center Drive, MSC 6600 Bethesda, MD 20892-6600 Telephone: 301-594-8877 FAX: 301-480-8300 Email: [email protected] For other applications, please note the following: Program Officers in the Complications and Co-Infections Research Branch, DAIDS may be contacted at (301) 435-3769 or through the NIAID/DAIDS website, http://www.niaid.nih.gov/ncn/staff/contactdaids.htm#ccib. At any time, potential applicants can obtain a current listing of active NIAID PAs on the NIAID WWW site at URL: http://www.niaid.nih.gov/ncn/budget/pas.htm
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |